Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Philip Droznika Insider Profile
4 Followers
Philip Droznika, Director at PsyBio Therapeutics, holds 340.91K shares in PsyBio Therapeutics (Ticker: TSE:PSYB.H). Most recently, Philip Droznika Bought C$90,909 shares of PsyBio Therapeutics on Jul 14, 2017 for an estimated value of 5.00K.
Philip Droznika has not reported sufficient informative transactions and therefore cannot be ranked.
Time Frame
Compare to
Insider Holdings
100.00%
A breakdown of Philip Droznika's holdings
Insider Roles
Director
Roles that Philip Droznika holds in companies
Most Profitable Insider Trade
Currently, no data available
The most profitable trade made by Philip Droznika
Philip Droznika's Trading History
List of latest transactions for each holding click on a transaction to see Philip Droznika's performance on stock
You May Also Like
Philip Droznika insider profile FAQ
What is the percentage of profitable transactions made by Philip Droznika?
The percentage of profitable transactions made by Philip Droznika is ―.
What is the average return per transaction made by Philip Droznika?
The average return per transaction made by Philip Droznika is ―.
What stocks does Philip Droznika hold?
Philip Droznika holds: TSE:PSYB.H stocks.
What was Philip Droznika’s latest transaction?
Philip Droznika latest transaction was an Informative Buy of C$5.00K.
What was Philip Droznika's most profitable transaction?
Philip Droznika’s most profitable transaction was an Uninformative Buy of stock on ―. The return on the trade was ―.
What is Philip Droznika's role in PsyBio Therapeutics?
Philip Droznika's role in PsyBio Therapeutics is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.